BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Kyle Rose does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 RBOTVicarious Surgical Inc. | Buy | $9.00 | May 2023 | −98.4% | Miss |
 TELATela Bio Inc | Buy | $15.00 | Mar 2023 | −67.0% | Miss |
 KRMDRepro Med Systems Inc | Buy | $4.00 | Nov 2022 | −24.3% | Hit |
 SNNSmith & Nephew SNATS Inc | Buy | $55.00 | Apr 2021 | −31.5% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.